Etanercept and psoriasis

NEW YORK, July 31 (Praxis Press) Patients with psoriasis and psoriatic arthritis have increased concentrations of tumor necrosis factor in their skin lesions and joints. Mease and colleagues studied psoriasis disease activity in 30 patients randomized to receive etanercept, an inhibitor of tumor necrosis factor, and in 30 patients randomized to receive placebo. After 12 weeks of treatment, the median improvements in psoriasis area and severity index scores were 46.2% for etanercept-treated patie

August 1, 2000

NEW YORK, July 31 (Praxis Press) Patients with psoriasis and psoriatic arthritis have increased concentrations of tumor necrosis factor in their skin lesions and joints. Mease and colleagues studied psoriasis disease activity in 30 patients randomized to receive etanercept, an inhibitor of tumor necrosis factor, and in 30 patients randomized to receive placebo. After 12 weeks of treatment, the median improvements in psoriasis area and severity index scores were 46.2% for etanercept-treated patients and 8.7% for placebo-treated patients (P = 0.0032). Etanercept-treated patients with psoriatic arthritis were more likely to meet Psoriatic Arthritis Response Criteria (P < 0.0001) and American College of Rheumatology preliminary criteria for improvement (P < 0.0001). Rates of respiratory tract infection and injection site reaction were similar for the two groups. Etanercept may be a safe alternative to current drugs for the treatment of psoriasis and psoriatic arthritis.

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham